Diet Aid

Pfizer Leans On Lipitor, Cost Cutting

forbes.com     9 hrs ago   104 related          

Despite generic drugs and health concerns encroaching on sales in the second quarter, Pfizer managed to grow its bottom line. On Wednesday, the New York City-based pharmaceutical giant became the third large U.S. drug company...                

comments

                   

GSK chief outlines ways to steady course

newsobserver.com     6 hrs ago   17 related          

Profits dip, and near future looks worse Witty took over from Jean-Pierre Garnier in May. Sabine Vollmer, Staff WriterComment on this story Andrew Witty, GlaxoSmithKline's new chief executive, took charge of his first quarterly...                

comments

                   

Diabetes Drug Avandia Causes Brittle Bones, Researchers Declare

newstarget.com     10 hrs ago          

The widely used diabetes drug rosiglitazone, marketed as Avandia, may increase the risk of brittle bones and osteoporosis, according to a new study conducted by researchers from the Salk Institute in La Jolla, California, and...                

comments

                   

GSK net profit down by 3.5% to GBP1.3 bn inQ2

pharmiweb.co.uk     1 hr ago   1 related          

Our Bureau, Mumbai GlaxoSmithKline Plc. (GSK), the UK based second largest pharmaceutical company in the world, has suffered minor setback during the second quarter ended June 2008 due to generic competition in the USA and...                

comments

                   
cnn.com: Zocor, and its generic simvastatin, are widely prescribed cholesterol-lowering drugs. cnn.com

Gene may help ID statin side effect risk

cnn.com     13 hrs ago   33 related          

Cholesterol-lowering statins can cause muscle pain and weakness Genetic variation seems to predict patients who'll get side effects Experts: The finding doesn't mean all statin takers should be tested Muscle weakness caused by...                

comments

                   

Glaxo second-quarter earns down 3 percent as generic competition continues to bite

iht.com     22 hrs ago   22 related          

GlaxoSmithKline PLC, the world's second largest drug maker, posted a 3 percent fall in second quarter net profit on Wednesday after strong competition from generic drugs outweighed asset sales and the cost-saving effects of job...                

comments

                   

Merck and Schering-Plough prepare Vytorin letter

ibtimes.com     15 hrs ago   8 related          

Vytorin partners Merck & Co. and Schering-Plough Corp. have prepared a letter for physicians who might be concerned over recent study results that showed patients taking the cholesterol drug were at higher risk of dying from...                

comments

breakingnews.ie: The new head of GlaxoSmithKline today said the drug giant must change to survive the growing threat of generic competition for its leading products. breakingnews.ie

GlaxoSmithKline's profit falls

charlotte.com     22 hrs ago   11 related          

GlaxoSmithKline’s revenue and profit decreased 2 percent in the second quarter as sales of diabetes drug Avandia continued to drop.The British drug maker, which has a U.S. headquarters and a manufacturing plant in the Triangle,...                

comments

Pfizer's profit doubles on lower costs, favorable exchange rate

marketwatch.com     23 hrs ago   2 related          

By Val Brickates Kennedy, MarketWatch BOSTON (MarketWatch) -- Pfizer, the world's largest drugmaker, reported that its second-quarter profit more than doubled, due largely to a favorable currency exchange rate and lower costs....                

comments

                   

Statins may help kidney transplant patients: study (Reuters)

yahoo.com     14 hrs ago   19 related          

By Will Dunham 1 hour, 19 minutes ago WASHINGTON (Reuters) - Cholesterol-fighting statin drugs, already known to help ward off heart attack and stroke, may help people who have received a kidney transplant live longer,...                

comments

1 2 3 4 5 next »